November 2017 VOL 8, NO 11
← Back to Issue
Letters from Lillie
AONN+ to Present Evidence-Based Navigation Research Abstracts at Annual Conference
Lillie D. Shockney, RN, BS, MAS, ONN-CG,
The Johns Hopkins Breast Center; the Sidney Kimmel Cancer Center at Johns Hopkins,
In this issue of the Journal of Oncology Navigation & Survivorship (JONS), we are proud to present the evidence-based research abstracts that have been accepted to the Eighth Annual Navigation & Survivorship Conference of the Academy of Oncology Nurse & Patient Navigators (AONN+).
This year, our categories were updated to reflect the 8 domains of navigation recognized by the Academy as part of its metrics initiative. I’d like to mention that the Academy also recognizes that there are clinical topics of interest that may not directly impact our role as navigators but are important to our field at large. To this end, we host a special category (Category IX) to acknowledge advances in oncology research. The categories for abstracts are:
- Category I: Community Outreach/Prevention
- Category II: Care Coordination/Care Transitions
- Category III: Patient Advocacy/Patient Empowerment
- Category IV: Psychosocial Support, Assessment
- Category V: Professional Roles and Responsibilities
- Category VI: Research, Quality, Performance Improvement
- Category VII: Operations Management, Organizational Development, Health Economics
- Category VIII: Survivorship and End of Life
- Category IX: Clinical Research
I am hopeful that the aligning of research abstract categories with the metric domains encourages you to participate in implementing metrics at your institution as well as to collect the data from your metrics assessment. Through implementation, assessment, collection of data, and shared best practices, we will continue to elevate the importance of navigation in our oncology institutions nationwide.
I hope to see many of you this month in Orlando at the AONN+ conference, where you will have the opportunity to meet the authors of these abstracts as well as to attend sessions led by the best in the navigation field.
Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+
University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship
Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
Background: Ibrutinib, a B-cell receptor pathway inhibitor, is approved in the United States for the treatment of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and allows for treatment without [ Read More ]
Background: Patient navigation has been shown to improve patient engagement and participation in clinical trials1-3 and reduce barriers to cancer care.4,5 Despite growing evidence of value, oncology patient navigation is [ Read More ]